NCT03353012View on ClinicalTrials.gov

Acceptability & Tolerance of Immediate Versus Delayed Postpartum Contraceptive Implant

PHASE4CompletedINTERVENTIONAL
Enrollment

60

Participants

Timeline

Start Date

January 1, 2018

Primary Completion Date

May 1, 2018

Study Completion Date

August 1, 2018

Conditions
BreastfeedingPost Partum
Interventions
DRUG

Etonogestrel Drug Implant

Etonogestrel 68 mg (single rod) is implanted at inner arm of participant.

DRUG

Levonorgestrel Drug Implant

Levonorgestrel 75 mg (2 rods) are implanted at inner arm of participant.

Trial Locations (1)

10330

King Chulalongkorn Memorial Hospital, Pathum Wan

All Listed Sponsors
lead

Chulalongkorn University

OTHER

NCT03353012 - Acceptability & Tolerance of Immediate Versus Delayed Postpartum Contraceptive Implant | Biotech Hunter | Biotech Hunter